Newsletter
305 – Overcoming medication safety and operational efficiencies associated with controlled drugs in healthcare. James Gold, Modeus

Talking HealthTech

305 – Overcoming medication safety and operational efficiencies associated with controlled drugs in healthcare. James Gold, Modeus

Overcoming medication safety and operational efficiencies associated with controlled drugs in healthcare settings   At Modeus, James Gold handles C-level connections with clients, vendor partners, and jurisdictional health agencies in…
November 3, 2022

305 – Overcoming medication safety and operational efficiencies associated with controlled drugs in healthcare. James Gold, Modeus

Overcoming medication safety and operational efficiencies associated with controlled drugs in healthcare settings

 

At Modeus, James Gold handles C-level connections with clients, vendor partners, and jurisdictional health agencies in addition to leading the business development and account management teams.

Modeus is one of Australia’s largest healthcare software providers, servicing over 5,500 customers across multiple industries including pharmacy, veterinary, aged care, hospital, paramedic services, and medication warehousing & distribution.
This episode is about the myriad of issues associated with traditional controlled drug administration and how they impact healthcare settings. 

 

Check out the episode and full show notes here.

To see the latest information, news, events and jobs on offer at Modeus, visit their Talking HealthTech Directory here

Loving the show?  Leave us a review, and share it with someone who might get some value from it.

Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits and more exclusive content.  For more information visit here.

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Adopting Clinical Trial Technology: The Key to Success for Patients, Sites, & Researchers Adoption of new clinical trial technologies is critical to success. These innovations can lift patient burden, improve patient engagement, and increase equity and access to clinical trials.